Skip to main content

AbbVie Inc. ratios

  • ABBV · NYSE
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$295.03+0.20%Close 13 Nov 2026 · Market value $524.5B

In fiscal 2025 (the year to 31 Dec 2025), AbbVie Inc. had an operating margin of 24.6%, a return on invested capital of 9.5%.

From AbbVie Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

AbbVie Inc. ratios, annual
USDFY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Gross margin73.4%75.5%75.6%77.8%80.3%77.2%75.0%76.4%77.6%66.4%69.0%70.0%62.4%70.0%70.2%
Operating margin20.8%31.6%30.1%17.1%33.0%36.4%33.8%19.5%39.0%24.8%31.9%31.2%23.5%16.2%24.6%
Net margin19.7%28.7%22.0%8.9%22.5%23.2%18.8%17.4%23.7%10.1%20.5%20.4%9.0%7.6%6.9%
Free cash flow margin33.8%32.7%30.7%14.7%30.6%25.6%33.4%39.0%38.4%36.7%39.1%41.8%40.6%31.7%29.1%
Return on equity——199%56.9%181%139%109%——188%81.0%72.5%35.2%——
Return on assets—19.8%15.6%9.0%14.5%11.8%9.6%7.7%16.4%7.5%10.7%11.2%7.3%5.3%7.2%
Return on capital employed—28.8%26.6%17.7%25.9%19.0%17.3%13.3%22.5%11.6%15.4%16.4%12.4%9.5%16.1%
Return on invested capital—40.3%33.5%17.8%21.2%15.8%12.3%9.8%26.8%10.3%12.5%13.4%9.1%7.0%9.5%
Current ratio—2.272.591.411.501.651.280.983.180.840.790.960.870.660.67
Debt to equity——3.288.608.037.957.33——6.665.033.725.8220.46—
Net debt / EBITDA—1.100.741.572.782.892.503.961.814.412.562.072.213.562.72
Interest coverage—55.9318.947.9510.488.928.304.747.284.637.408.125.743.255.21
Cash conversion172%114%140%166%136%110%178%225%162%364%191%205%454%417%422%
Dividend payout——61.9%150%64.0%62.4%77.4%98.1%80.8%167%80.2%84.9%217%258%276%
SBC / Revenue0.9%1.0%1.1%1.2%1.2%1.4%1.3%1.3%1.3%1.6%1.2%1.2%1.4%1.6%1.6%

Quarterly

AbbVie Inc. ratios, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Gross margin60.1%66.7%70.9%70.9%70.9%70.0%71.8%66.4%72.6%71.9%74.7%75.4%
Operating margin22.3%22.7%27.6%26.5%−9.9%28.0%31.7%12.1%27.3%26.6%37.9%36.0%
Net margin5.7%11.1%9.5%10.8%−0.1%9.6%6.1%1.2%10.9%4.6%21.3%24.2%
Free cash flow margin31.8%31.3%14.0%35.9%44.7%10.5%31.7%42.1%29.4%23.8%18.3%42.0%
Return on equity7.9%17.1%——————————
Return on assets1.6%1.5%1.8%2.0%−0.9%2.1%2.2%1.1%2.3%2.0%4.0%3.7%
Return on capital employed3.3%2.6%4.0%3.8%−1.5%3.7%5.0%2.0%5.0%4.2%6.9%6.0%
Return on invested capital2.1%1.9%2.3%2.5%−1.1%2.8%2.8%1.5%3.1%2.6%5.3%4.8%
Current ratio0.870.940.810.650.660.760.740.720.670.800.810.87
Debt to equity5.829.2410.4211.7820.4649.22——————
Net debt / EBITDA9.0111.489.4510.77102.0711.219.1715.789.6610.717.728.60
Interest coverage5.664.245.515.32−2.125.336.612.586.365.568.627.81
Cash conversion553%281%148%333%−30714%109%521%3572%269%513%86.2%173%
Dividend payout319%202%201%176%—227%310%1565%160%444%85.0%72.8%
SBC / Revenue0.9%2.8%1.5%1.3%1.1%3.1%1.2%1.3%0.9%3.0%1.0%0.9%

The main figures as JSON and plain text. See data and methodology.

ABBV in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.